Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines.
Open accessThe DOI matches its Crossref record.
Abstract
The glycoproteins granule membrane protein 140 (GMP140), endothelial-leukocyte adhesion molecule 1 (ELAM-1), and Leu-8 are members of a family of glycoprotein receptors (selectins or LEC-CAMs) that play an important role in adhesive interactions between circulating leukocytes and vascular endothelium. Recently it has been reported that ELAM-1 is able to mediate the binding of the colon carcinoma cell line HT-29 to cytokine-activated vascular endothelium, suggesting that tumor cell adhesion to vascular endothelium, a prerequisite for tumor extravasation and metastasis, is in part the result of adhesive interactions between blood-borne tumor cells and cell surface proteins expressed by vascular endothelium. Here, using an approach in which soluble immunoglobulin chimeras of the GMP140 and ELAM-1 receptors were prepared and used to carry out immunohistological studies, we establish that GMP140 binds to tumor cells in a variety of human carcinoma tissue sections (colon, lung, and breast), whereas ELAM-1 binds exclusively to tumor cells in colon carcinoma tissue sections. In addition, GMP140 was found to bind to the cell surface of a number of cell lines derived from various carcinomas but not from melanomas, whereas ELAM-1 bound only colon carcinoma cell lines. We further investigated the nature of the ligands of GMP140 and ELAM-1 on the surface of the carcinoma cells and found that the GMP140 ligand on the surface of tumor cells appears to be distinct from that expressed on the myeloid cell line HL-60. Neuraminidase treatment of a breast carcinoma cell line does not affect, or in some instances increases, GMP140 binding, whereas it completely abolishes GMP140 binding to HL-60 cells. On the other hand, the ligand of ELAM-1 on both the colon carcinoma and HL-60 cells is neuraminidase sensitive in accord with its identification as sialyl-CD15. Parallel results were obtained with neuraminidase-treated frozen carcinoma tissue sections. The present findings form the basis for investigating the role of GMP140 in tumor invasiveness and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Perspectives on the significance of altered glycosylation of glycoproteins in cancer
Kim, Y. J., & Varki, A. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018580324971 · Cited by 535
Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells.
Moore, K. L., Stults, N. L., Diaz, S., Smith, D. F., Cummings, R. D., Varki, A., & McEver, R. P. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.2.445 · Cited by 514
Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05530.x · Cited by 511
Self-citationP-selectin deficiency attenuates tumor growth and metastasis
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9325 · Cited by 454
Koenig, A., Norgard-Sumnicht, K., Linhardt, R., & Varki, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1509 · Cited by 403
Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Peach, R., Hollenbaugh, D., Stamenkovic, I., & Aruffo, A. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.257 · Cited by 378
Self-citationExpression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.
Mueller, B. M., Reisfeld, R. A., Edgington, T. S., & Ruf, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11832 · Cited by 356
CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells
Aigner, S., Sthoeger, Z. M., Fogel, M., Weber, E., Zarn, J., Ruppert, M., Zeller, Y., Vestweber, D., Stahel, R., Sammar, M., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3385 · Cited by 325
Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer
Kannagi, R. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018532409041 · Cited by 321
Platelets and cancer metastasis: A causal relationship?
Honn, K. V., Tang, D. G., & Crissman, J. D. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307186 · Cited by 289
CD24 mediates rolling of breast carcinoma cells on P‐selectin
Aigner, S., Ramos, C. L., Hafezi‐Moghadam, A., Lawrence, M. B., Friederichs, J., Altevogt, P., & Ley, K. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1241 · Cited by 282
Emdad, L., Sarkar, D., Su, Z.-Z., Randolph, A., Boukerche, H., Valerie, K., & Fisher, P. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3029 · Cited by 276
Delayed Mammary Tumor Progression in Muc-1 Null Mice
Spicer, A. P., Rowse, G. J., Lidner, T. K., & Gendler, S. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30093 · Cited by 266
Cell Adhesion Molecules—Update
Elangbam, C. S., Qualls, C. W., & Dahlgren, R. R. (1997) · Veterinary Pathology · doi:10.1177/030098589703400113 · Cited by 215
Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells.
Levinovitz, A., Mühlhoff, J., Isenmann, S., & Vestweber, D. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.2.449 · Cited by 188
“Analogous fusion proteins for human E-and P-selectin have also been used in various carbohydrateligand binding studies (Walz et al., 1990; Aruffo et al., 1991; Erbe et al., 1992), and in immunohistology experiments on tumor tissue (Aruffo et al., 1992).”
Capila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Metadata
- Authors
- Aruffo, A., Dietsch, M. T., Wan, H., Hellström, K. E., & Hellström, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-03-15
- Volume
- 89
- Issue
- 6
- Pages
- 2292-2296
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2088937717
- Cited by
- 91
- References
- 0
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.